Literature DB >> 1437247

2-D and 3-D computed tomography and magnetic resonance imaging in developmental dysplasia of the hip.

D Atar1, W B Lehman, A D Grant.   

Abstract

Clinical examination and plain roentgenograms have been the main methods of diagnosis and treatment of developmental dysplasia of the hip. Occasionally, concentric reduction cannot be achieved, or the reduction is questionable. A dynamic arthrogram can add more information but is usually performed under general anesthesia. "Mini" computed tomographic imaging demonstrates the femoral head-acetabulum relationship more accurately and produces minimal radiation. Three-dimensional computed tomography is useful in older children, in whom all sections are ossified. Magnetic resonance imaging, particularly 3-D magnetic resonance imaging, demonstrates the nonossified structures. It is the best method of visualization in developmental dysplasia of the hip. The disadvantages of this method include its cost and the lack of dynamic imaging. In the future, new software will overcome these shortcomings.

Entities:  

Mesh:

Year:  1992        PMID: 1437247

Source DB:  PubMed          Journal:  Orthop Rev        ISSN: 0094-6591


  3 in total

1.  Relationships of hip joint volume ratios with degrees of joint laxity and degenerative disease from youth to maturity in a canine population predisposed to hip joint osteoarthritis.

Authors:  Laura L D'Amico; Lin Xie; Lindsey K Abell; Katherine T Brown; Mandi J Lopez
Journal:  Am J Vet Res       Date:  2011-03       Impact factor: 1.156

2.  Utility of magnetic resonance imaging (MRI) after closed reduction of developmental dysplasia of the hip.

Authors:  Manon Bachy; Camille Thevenin-Lemoine; Amélie Rogier; Pierre Mary; Hubert Ducou Le Pointe; Raphaël Vialle
Journal:  J Child Orthop       Date:  2012-01-11       Impact factor: 1.548

3.  Anterior axial ultrasound in monitoring infants with Pavlik harness.

Authors:  Julie El Ferzli; Saad Abuamara; Danielle Eurin; Patrick Le Dosseur; Jean-Nicolas Dacher
Journal:  Eur Radiol       Date:  2003-06-12       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.